An experimental Ebola vaccine partially designed at Canada's National Microbiology Laboratory was found to be highly protective in a major clinical trial in Guinea, suggesting future outbreaks could be easily contained.
from CBC | Health News http://ift.tt/2ihHLHM
Aucun commentaire:
Enregistrer un commentaire